🐋 NVDA: $18.7M Calendar Roll — Smart Money Stays Above $195 Through GTC Week!

📅 March 12, 2026 | 🔥 Unusual Activity Detected

---

🎯 The Quick Take

Someone just paid a net $18.7M to roll their entire $195 call position from March 20 expiration into May 15 — and the timing is no accident. With NVIDIA's GTC 2026 conference kicking off in just 4 days (March 16-19), this whale is staying long above $195 straight through Jensen Huang's "world-surprising" chip keynote and all the way to Q1 FY2027 earnings in May. Translation: institutional money just planted a flag at $195 and paid $18.7M to keep it there.

---

📊 Company Overview

NVIDIA Corporation (NVDA) is the undisputed king of AI compute infrastructure:

• Market Cap: ~$4.52 Trillion (one of the most valuable companies on Earth)
• Industry: Semiconductors & Related Devices
• Current Price: $182.07 (spot at time of trade), $183.52 (gamma chart reference)
• Primary Business: GPU accelerators dominating AI training and inference — Data Center segment now represents over 91% of total revenue. NVIDIA's CUDA software ecosystem, NVLink interconnects, and full-stack platform (chips + networking + software) create a competitive moat virtually no competitor has been able to replicate.

NVIDIA just reported record fiscal Q4 2026 revenue of $68.1 billion — up 73% year-over-year — and guided Q1 FY2027 to $78 billion. The AI infrastructure supercycle is not slowing down.

---

💰 The Option Flow Breakdown

The Tape (March 12, 2026 @ 10:51:58 — Calendar Spread executed simultaneously):

Combined Strategy: Calendar Call Spread Roll

• Leg 1 (Buy): May 15 $195 Call — paid $21M
• Leg 2 (Sell): March 20 $195 Call — collected $2.3M
• Net Debit: ~$18.7M ($21M - $2.3M)

---

🤓 What This Actually Means

This is a calendar roll — and it's one of the most deliberate, strategic plays you'll see. Here's what happened:

• 📅 Someone already owned the March 20 $195 calls. Those are expiring in just 8 days and with NVDA at $182, they're deeply out-of-the-money with almost no intrinsic value — just $0.83 left.
• 🔄 Instead of letting them die worthless, they rolled. They sold those nearly-dead March calls and used the proceeds to buy May 15 calls at the exact same $195 strike. Net cost to roll: $18.7M.
• ⏰ Why keep $195 exposure through May 15? Because GTC 2026 (March 16-19) and Q1 FY2027 earnings (~May 27) are both inside that window. This whale is not closing the trade — they're EXTENDING their upside bet.
• 🎯 The strike is not random. $195 is 7.1% above the current spot of $182. They need NVDA to run significantly. That's either GTC euphoria, earnings beat, or both.
• 💸 Scale check: 27,440 contracts = 2.744 million shares of NVDA exposure. At $182 spot, that's a notional equity exposure of ~$500M. The $18.7M roll cost is essentially the "renewal fee" on a half-billion-dollar options position.

What's really happening here: This trader had a big NVDA call position into GTC week. Rather than abandoning ship when the stock pulled back from its $212 all-time high, they paid $18.7M to keep the exact same $195 upside conviction alive for 2 more months. Think of it as renewing a $500M bet with a $18.7M renewal fee — they want to stay in the game through every catalyst on the NVDA calendar between now and May 15.

---

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

NVDA started 2026 near its all-time high of $212.19 and has pulled back roughly 12% YTD to the $182-186 range. Despite record Q4 FY2026 earnings on February 25, the stock saw classic "sell the news" price action as the market digested a +73% YoY revenue print that had been largely anticipated. The stock is now consolidating in what many analysts view as a healthy reset ahead of GTC.

Key chart observations:

• 📉 12% pullback from ATH: Down from $212.19 to low-$180s — the DeepSeek shock in January erased ~$600B in market cap intraday; partial recovery since
• 🎯 Consolidation zone: Trading in $180-190 range with multiple tests of $182-183 support
• 📊 52-week range: $86.62 – $212.19 — the stock has more than doubled from its 52-week low
• ⚠️ Elevated implied vol: Calendar spreads on this stock have complex Greeks — vol levels matter

---

Gamma-Based Support & Resistance Analysis

Current Price: $183.52

The gamma exposure map shows a battlefield of powerful levels packed tightly around current price — this is the kind of gamma environment that creates explosive moves when price breaks free of a key level.

🔵 Support Levels (Put Gamma — Dealer Buying Below Price):

• $182.50 — Immediate floor with net GEX +33.98, total 93.47. This level is holding the stock right now.
• $180.00 — Major structural support at total GEX 225.81 (strongest put gamma level!) — this is the LINE IN THE SAND for the near-term bull case
• $175.00 — Extended support at 92.53 total GEX — if $180 cracks, this is where dealers reload

🟠 Resistance Levels (Call Gamma — Dealer Selling Above Price):

• $185.00 — Immediate resistance with 375.98 total GEX — MASSIVE wall, the single strongest level on the entire chart. Market makers will systematically sell into every rally toward this level.
• $190.00 — Secondary ceiling at 232.17 GEX — above $185 and this becomes the next target
• $195.00 — 131.77 total GEX — EXACTLY where this calendar spread is positioned! Not a coincidence.
• $200.00 — Extended resistance at 191.87 GEX — the "home run" level for this trade

What this means for traders: NVDA is pinned between $182.50 support and $185 resistance with a MONSTER call gamma wall overhead. The $185 wall (375.98 GEX — the largest single level) will be the biggest obstacle between current price and the $195 strike. To get this trade profitable, NVDA needs to break through $185, then $190, and then reach $195. That's a 7% move from current levels — completely achievable over 65 days if GTC delivers.

The key insight: This whale placed their roll at $195 — a level that shows up clearly on the gamma map with 131.77 GEX. They know this level. They positioned there deliberately.

Net GEX Bias: Bullish (call GEX 1,491 >> put GEX 803) — overall options positioning remains bullish. The gamma structure supports upside momentum once $185 is cleared.

---

Implied Move Analysis

Options market pricing for upcoming expirations:

• 📅 Weekly (March 13 — 1 day): ±1.63% = ±$2.98 → Range: $180.17 – $186.13
• 📅 Monthly OPEX (March 20 — Triple Witch + GTC week): ±4.75% = ±$8.69 → Range: $174.46 – $191.84
• 📅 May 15 OPEX (THIS TRADE): Range: $165.82 – $200.48
• 📅 LEAP (March 2027): ±31.57% → Range: $125.33 – $240.97

Translation for regular folks: The options market is pricing in a 4.75% move by March 20 — that's Triple Witch and GTC week. But the May 15 window (when this calendar trade expires) spans a massive $165.82–$200.48 range. The upper end of that range at $200.48 is RIGHT where this trade starts to pay off big — the $195 strike would be deeply in the money.

Notice the weekly (next day) range of $180.17–$186.13 perfectly frames the current support/resistance battle. NVDA is threading the needle right between $182.50 support and the $185 resistance wall. The next 48 hours will set the tone heading into GTC.

---

🎪 Catalysts

🔥 Upcoming Catalysts (Next 3 Months)

CRITICAL: GTC 2026 — March 16-19, 2026 (San Jose, California) — 4 DAYS AWAY! 🚀

This is the single biggest near-term catalyst on the NVDA calendar and the PRIMARY reason for this calendar roll.

• Keynote: Monday, March 16, 11:00 a.m. – 1:00 p.m. PT, SAP Center, San Jose — livestreamed free at nvidia.com/gtc
• Scale: 30,000+ in-person attendees from 190+ countries
• Jensen's promise: He teased a "world-surprising" chip reveal — expectations are elevated

What analysts expect at the keynote:

1. 🔬 "World-surprising" chip reveal — Could be Feynman architecture details (2028), accelerated Vera Rubin Ultra roadmap, or a new networking/system product announcement
2. 🖥️ Vera Rubin platform deep-dive — Full architectural presentation of the Vera Rubin NVL72: 72 Rubin GPUs + 36 Vera CPUs, 260 TB/s NVLink 6 bandwidth — targeting 2H 2026 volume shipments
3. 🤖 Agentic AI software updates — NIM microservices, NeMo Agent toolkit, NVIDIA Dynamo inference optimization
4. 🌍 New sovereign AI partnerships — Beyond Saudi Arabia ($15-20B HUMAIN deal) and South Korea (260,000-chip rollout), additional nation-state announcements expected
5. 🤖 Physical AI / Robotics demos — Isaac platform, Omniverse, Cosmos digital twin updates

Why this calendar roll is GTC-specific: The March 20 call (8 days away) would expire RIGHT AFTER the GTC keynote. If GTC disappoints, those March calls die. The trader just paid $18.7M to NOT be forced to close if GTC is mixed — they now have 65 more days for the thesis to play out.

---

Q1 FY2027 Earnings Report — Expected ~May 27, 2026 📊

NVDA guided Q1 FY2027 to $78.0B ±2% in revenue — a 14.5% sequential increase from an already record-setting quarter. Key things to watch:

• Revenue guidance range: $76.4B–$79.6B (company's own midpoint)
• Non-GAAP gross margin: ~75.0%
• Data Center trajectory toward $70B+ quarterly
• Vera Rubin ramp timeline update
• China revenue: Currently assumed at $0 by NVIDIA itself — any positive surprise is pure upside

The May 15 expiration on the long leg of this spread captures this earnings cycle. If NVDA beats and guides up again, $195+ becomes highly realistic.

---

Hyperscaler Capex Machine — $650B+ Committed for 2026 💰

This is the engine underneath everything:

Wall Street originally modeled only 19% capex growth for 2026 — actual guidance implied +70% to roughly $650B aggregate. Amazon alone announced a $38B partnership to run AI models on hundreds of thousands of NVIDIA chips.

---

📋 Recent Catalysts (Already Happened)

Q4 FY2026 Earnings Beat (February 25, 2026) — Record Everything

• Total Revenue: $68.1B (+73% YoY) — beat consensus
• Data Center Revenue: $62.3B (+75% YoY)
• Non-GAAP EPS: $1.62 vs. $1.53 estimate (+6% beat)
• Free Cash Flow: $35.0B (+127% YoY)
• Full-Year FCF (FY2026): $97.0B

Despite the massive beat, the stock saw "sell the news" action — creating the exact pullback this calendar roll is positioned to recover from.

Vera Rubin Platform at CES 2026 (January 5-7)

Jensen Huang unveiled Vera Rubin NVL72 at CES: 50 petaflops FP4 (2.5x Blackwell per chip), HBM4 memory at 22 TB/s, TSMC 3nm, targeting 2H 2026 volume shipments — 10x inference token cost reduction vs. Blackwell platform.

China Export Control Relaxation (January 15, 2026)

BIS changed H200 review policy from "presumption of denial" to "case-by-case" — potential $5-10B+ annual revenue optionality, though NVDA guides $0 China revenue in Q1 FY2027. Any positive surprise here is pure upside.

DeepSeek Shock and Recovery (January 2026)

The emergence of DeepSeek's efficient models triggered a ~$600B single-day market cap wipeout — the largest single-day market cap loss in U.S. stock history at the time. NVDA has since partially recovered as Jensen Huang's "Jevons Paradox" argument — more efficient inference means MORE total compute demand — was validated by the hyperscaler capex surge.

---

🎲 Price Targets & Probabilities

Using gamma levels, implied move data, and the catalyst calendar through May 15:

📈 Bull Case (35% probability)

Target: $195-$205

How we get there:

• 🚀 GTC keynote (March 16) delivers on the "world-surprising" chip — Vera Rubin timeline accelerates or Feynman teaser blows minds
• 📊 Post-GTC momentum carries NVDA through the $185 gamma wall and into the $190-195 zone
• 🌍 Additional sovereign AI deal announcements at GTC (beyond Saudi Arabia and South Korea) add headline firepower
• 💰 Q1 FY2027 earnings ~May 27 beat the $78B guidance — particularly if China revenue surprises or gross margin expands beyond 75%
• 📈 May 15 implied move upper end sits at $200.48 — the market is already pricing this scenario as within its 1-standard-deviation range
• ✅ This calendar trade profits handsomely. The May 15 $195 calls with NVDA at $200 would be worth ~$7-8+ each

Probability rationale: 35% — GTC has been a historical stock catalyst, the "world-surprising" tease sets a high bar but Jensen rarely disappoints on his home stage. The catalyst density between now and May 15 is extraordinary.

---

🎯 Base Case (45% probability)

Target: $180-$192 (Volatile Consolidation)

Most likely scenario:

• 📊 GTC delivers solid but not shocking news — Vera Rubin update in line with CES announcements, new software/sovereign deals, but no architectural bombshell
• 🎢 Stock rallies to $188-192 on GTC week then consolidates as market digests
• 📅 March 20 Triple Witch OPEX creates mechanical selling pressure around the $185-190 zone
• ⚖️ Q1 earnings (~May 27) in line with $78B guidance — no major upside surprise
• 💤 May 15 calls expire with NVDA at $185-192 — the trade loses value on the long side
• 📉 Net result: The $18.7M roll loses a significant portion of value, but the trader avoids the catastrophic complete loss they would have taken if GTC was mixed and March 20 calls expired worthless

Why this matters: The roll was defensive insurance as much as it was offensive positioning. In the base case, the trader loses money on the net debit but loses far LESS than if they had stayed in March calls.

---

📉 Bear Case (20% probability)

Target: $165-$178 (GTC Disappointment)

What could go wrong:

• 😰 Jensen's "world-surprising" chip reveal fails to surprise — Vera Rubin details already known, no Feynman acceleration, no new sovereign deals
• ⚠️ Classic "sell the news" GTC reaction — stock already priced for perfection, any shortfall triggers institutional profit-taking
• 🌍 Macro deterioration — broader tech selloff or escalating U.S.-China tensions hammer semis
• 🔨 DOJ antitrust probe escalation — formal complaint or consent decree becomes reality
• 📉 Break below $180 gamma support (225.81 GEX) triggers cascade toward $175 — implied move lower range for March 20 is $174.46
• 💀 May 15 $195 calls expire nearly worthless — entire $21M premium at risk on the long leg

Critical support levels to watch:

• 🛡️ $182.50 (93.47 GEX) — Current floor, must hold
• 🛡️ $180.00 (225.81 GEX) — Major gamma wall, the key battleground
• 🛡️ $175.00 (92.53 GEX) — Disaster scenario floor

---

💡 Trading Ideas

🛡️ Conservative: The "Piggyback the Whale" Stock Entry

Play: Buy NVDA stock on any dip to $180-$182 gamma support ahead of GTC

Why this works:

• 💰 $180 has 225.81 GEX — the strongest put gamma level on the chart. Market makers are mechanically buying puts at that level, creating a natural floor.
• 📅 GTC in 4 days is a known positive catalyst with 4.75% implied move. Entry at $180-182 gives a clean 7% run to $195 if GTC delivers.
• 🛡️ Stop loss below $175 (next gamma support) limits downside to ~3% while upside to $195 is 7-8%
• 💤 No options complexity — just owning the stock in the gamma support zone before the biggest catalyst of the year

Position sizing: 1-3% of portfolio. This is not a conviction long-term hold at $4.5T market cap — it's a tactical event play.

Risk level: Moderate (stock position) | Skill level: Beginner-friendly

Expected outcome: Stock trade from $180 to $190-195 during GTC week = 5-8% gain. Clean, simple, follows institutional momentum.

---

⚖️ Balanced: The "Long Call Diagonal" — Same Idea, Defined Risk

Play: Mirror the whale's positioning with a scaled-down version: buy the May 15 $190 call

Structure: Buy May 15 $190 Call (slightly closer to at-the-money than the $195 for better delta)

Why this works:

• 🎯 You get exposure to both GTC (March 16) and Q1 earnings (~May 27) with ONE options position
• 💰 The $190 strike is cheaper than $195 — better risk/reward if GTC is mixed but Q1 earnings deliver
• 📊 Defined risk: you can only lose what you pay for the call (vs. uncapped stock risk)
• ⏰ 65 days to May 15 — enough time for NVDA's multiple catalysts to materialize
• 🚀 If NVDA reaches $200 by mid-May, a $190 call could be worth 3-5x its current value

Estimated cost: ~$5-7 per contract (ask-side). 5 contracts = $2,500-3,500 risk, controls $100K in notional

Breakeven at May 15 expiration: $195-197 NVDA price

Risk level: Moderate | Skill level: Intermediate

Expected outcome: If NVDA reaches $195-200 by May 15 on GTC + earnings catalysts, the $190 call could pay out $8-12 on a $5-7 investment = 60-120% return.

---

🚀 Aggressive: The "GTC Sprint" — Short-Dated Call

Play: Buy March 21 (post-GTC) $187 or $188 call for a pure GTC event play

Why this could work:

• 💥 GTC keynote on March 16 is a massive binary event with ±4.75% implied move
• 🚀 Jensen's "world-surprising" chip tease sets up a potential pop through the $185 gamma wall
• 🎰 Short-dated calls are CHEAP right now — options expiring March 21 with strike $187-188 would cost very little in premium
• ⚡ If NVDA moves from $183 to $190 after GTC keynote, a $187 call could be worth 5-10x in a day

SERIOUS RISKS:

• 💸 Theta burns FAST on 1-week options — every day without a move is a loss
• 😱 IV crush post-keynote — even if NVDA rallies 2-3%, IV collapse could reduce option value
• 🎢 This is a YOLO bet. There's a high chance NVDA moves less than 4% during GTC week and this expires worthless.
• ⚠️ "World-surprising" is already priced in — the bar is HIGH. Investors who expected fireworks at Q4 earnings got a "sell the news" response despite a $2B revenue beat.

CRITICAL WARNING — Only attempt if you:

• ✅ Fully accept the possibility of 100% loss on this position
• ✅ Understand IV crush mechanics and have traded through event-driven volatility before
• ✅ Plan to close by end of day March 16 post-keynote regardless of outcome
• ✅ Are risking only play money — 1% or less of your portfolio maximum

Risk level: EXTREME (can lose 100%) | Skill level: Advanced only

Probability of profit: ~35% (high bar given "sell the news" risk at elevated valuations)

---

⚠️ Risk Factors

Don't get caught by these landmines:

• 🎪 GTC disappointment risk — the elephant in the room: Jensen Huang promised a chip meant to "surprise the world." That is an extraordinarily high bar. If the actual announcement is "just" a detailed Vera Rubin roadmap update — already announced at CES in January — the stock could sell off 5-8% as traders who bought the rumor sell the news. This has already happened once this year (February 25 earnings beat = stock sold off).

• 🏔️ $185 gamma wall is MASSIVE: At 375.98 total GEX, the $185 level has the single largest call gamma concentration on the entire chart. Market makers are mechanically selling against every rally into that level. To reach $195, NVDA needs to blast through $185, then $190, then face the $195 wall itself (131.77 GEX). That's three consecutive gamma walls in 7% of upside distance. Possible — but not easy.

• ⚖️ DOJ antitrust probe escalating: The Department of Justice investigation into NVIDIA's market conduct has already issued subpoenas to third parties. A formal complaint or consent decree in the May 15 window would be a significant negative catalyst. No resolution timeline is confirmed — these investigations typically span 2-5 years, but headlines can move stocks.

• 🇨🇳 China revenue zero — zero margin for positive: NVDA's own guidance assumes zero China Data Center revenue in Q1 FY2027. The BIS January 2026 rule change loosened H200 export restrictions, but any re-escalation in U.S.-China trade tensions — a real possibility under the current political environment — would add a new negative overhang.

• 🤖 DeepSeek-style efficiency shock: The January 2026 DeepSeek event wiped $600B in market cap in a single session. If another AI efficiency breakthrough emerges between now and May 15 that genuinely challenges the "more compute = better AI" narrative, this trade gets crushed. The frequency of these shocks appears to be increasing.

• 💰 Valuation offers no cushion: At ~$4.52T market cap and ~35x non-GAAP earnings, NVDA is priced for continuous perfection. The stock already corrected ~12% from its all-time high despite the most dominant quarterly earnings report in semiconductor history. Any single piece of bad news gets amplified when there's no valuation discount built in.

• 📉 Insider selling vs. buyback paradox: NVIDIA's board authorized $60B in buybacks while insiders sold over $1.6B in shares over the trailing 12 months. Bears highlight this as insiders quietly exiting at elevated prices while the company buys back stock with treasury cash.

• 🎢 May 15 is before earnings date (~May 27): The long leg expires May 15, but Q1 FY2027 earnings are expected around May 27. This means the calendar trade does NOT get to capture the actual earnings catalyst unless NVDA is already at $195+ before the call expires. The May 15 leg benefits from pre-earnings IV expansion but not from a post-earnings gap. This is an important structural limitation.

---

🎯 The Bottom Line

Real talk: This is one of the most deliberate option trades of 2026 so far. Someone holding a $500M notional NVDA position in $195 calls just looked at their expiring March contracts — worth barely $0.83 with NVDA 7% below strike — and said "not yet." They paid $18.7M to roll into May, keeping their exact $195 upside conviction alive through GTC, through Triple Witch, and all the way to Q1 earnings.

What this trade tells us:

• 🐋 This is not panic. Panicked traders don't structure sophisticated calendar rolls — they dump and walk away.
• 🎯 The $195 strike was chosen deliberately. It sits at a gamma level (131.77 GEX) that the trader clearly understands. At $195, NVDA has bounced before and broken resistance before. They want to be positioned THERE.
• ⏰ GTC in 4 days is the primary reason for rolling NOW instead of waiting. They needed the May expiry to not be forced out if March 20 expiration hits before the GTC catalyst fully plays out.
• 🔭 The May 15 expiry captures GTC announcements + post-GTC momentum + pre-earnings positioning + full earnings IV expansion. That's 4 separate catalyst windows in one trade structure.

The case calendar through May 15:

📅 March 16 — Jensen Huang keynote. Watch it live at nvidia.com/gtc. This is the pivotal moment. Everything this trade is banking on starts here.

📅 March 19 — GTC conference ends. Post-conference analyst reaction and revised price targets set the directional tone for the following weeks.

📅 March 20 — Triple Witch OPEX. Massive options expiration. The near-term leg of this calendar expired here — replaced by the May 15 long position.

📅 ~April–May — Vera Rubin 2H 2026 ramp news flow. Any production timeline updates, new customer commitments, or hyperscaler purchase orders translate directly to upside pressure.

📅 ~May 15 — This trade expires. If NVDA is above $195, the trader is sitting on significant profits on their long $195 call position. If below $195, the $21M premium paid for the May leg burns off.

📅 ~May 27 — Q1 FY2027 earnings. The long leg is already gone by then, but near-expiration IV expansion in late April/early May provides another monetization window for any remaining premium.

If you're following this trade:

• ✅ Watch GTC keynote Monday March 16 at 11 AM PT — this is the binary event that makes or breaks the near-term NVDA story
• 📊 Key number to watch: Does NVDA break above the $185 gamma wall post-keynote? Break above $185 = momentum trades activate and $190-195 comes into focus quickly
• 🛡️ Key support to watch: $180 (225.81 GEX) — if this cracks on a GTC disappointment, the sell-off could be steep to $175

If you're watching from the sidelines:

• ⏰ DO NOT chase before GTC keynote. The implied move says ±$8.69 for March 20 — you could be buying the top of a "buy the rumor" move. Wait for the keynote to clear.
• 🎯 Post-GTC entry at $183-185 (if stock holds support after the event) is a much better risk/reward than pre-event speculation
• 📅 Consensus analyst target is $263–$273 — that's 41% upside from current levels. If you have 6-12 months, the fundamental backdrop ($78B Q1 guidance, $650B hyperscaler capex, Vera Rubin ramp) remains extraordinary.

Final verdict: The whale who paid $18.7M to stay in this trade through May knows something simple — between GTC 2026 and Q1 earnings, NVDA has more potential positive catalysts packed into 65 days than almost any other large-cap stock on the market. Whether or not you follow the trade, you should absolutely be watching NVDA closely this week. The GTC 2026 keynote on March 16 could be the moment that either reignites the rally toward $212+ — or confirms the post-ATH consolidation is set to deepen. Either way, $18.7M just voted for the former.

This isn't YOLO. This is a calculated, strategic bet by someone who has done the work. Whether you agree with the thesis or not, respect the structure — and manage your own risk accordingly. 💪

---

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational and informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance of options strategies does not guarantee future results. Calendar spreads involve complex multi-leg dynamics including time decay, volatility changes, and liquidity risk on both legs. The unusual activity described reflects large institutional trades that may have portfolio construction, hedging, or risk management motivations not applicable or replicable by retail investors. Always conduct your own research and consider consulting a licensed financial advisor before placing any trade. Options can expire worthless, and it is possible to lose the entire premium paid.

---

Analysis Date: March 12, 2026 | NVDA Spot at Time of Trade: $182.07 | Charts: YTD, Gamma S/R, Implied Move